Abstract
The recent times have been difficult with the whole world fighting against the COVID-19 pandemic. A herbal home-based spice can help people improve their immunity and fight against this infection. Nigella sativa has been named as a prophetic spice as it has many therapeutic effects. It is found to control diabetes, reduce high cholesterol levels, and serve as an anti- oxidant, anti-cancer, anti-informatory, and immune booster. The compound thymoquinone can be responsible for enhancing the immune system as it acts as an anti-oxidant and has an anti-inflammatory property. Research has shown that to protect yourself from coronavirus, it is important to avoid human contact and strengthen the immune system. This paper is a review of various studies that prove that Nigella sativa can be beneficial in enhancing the immune system and thus fight COVID-19.
Keywords: COVID-19, coronavirus, immunity, Nigella sativa, kalonji, black cumin, onion seed.
Current Traditional Medicine
Title:Nigella sativa, as Preventive Strategy in COVID-19
Volume: 7 Issue: 4
Author(s): Vaishali Mathur and Mahak Sharma*
Affiliation:
- Department of Nutrition and Dietetics, Manav Rachna International Institute of Research and Studies, MAnav Rachna Campus, Sector 43, Delhi Surajkund Road, Faridabad,India
Keywords: COVID-19, coronavirus, immunity, Nigella sativa, kalonji, black cumin, onion seed.
Abstract: The recent times have been difficult with the whole world fighting against the COVID-19 pandemic. A herbal home-based spice can help people improve their immunity and fight against this infection. Nigella sativa has been named as a prophetic spice as it has many therapeutic effects. It is found to control diabetes, reduce high cholesterol levels, and serve as an anti- oxidant, anti-cancer, anti-informatory, and immune booster. The compound thymoquinone can be responsible for enhancing the immune system as it acts as an anti-oxidant and has an anti-inflammatory property. Research has shown that to protect yourself from coronavirus, it is important to avoid human contact and strengthen the immune system. This paper is a review of various studies that prove that Nigella sativa can be beneficial in enhancing the immune system and thus fight COVID-19.
Export Options
About this article
Cite this article as:
Mathur Vaishali and Sharma Mahak *, Nigella sativa, as Preventive Strategy in COVID-19, Current Traditional Medicine 2021; 7 (4) : e190122190566 . https://dx.doi.org/10.2174/2215083807666210121152731
DOI https://dx.doi.org/10.2174/2215083807666210121152731 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet the Editorial Board
Current Drug Targets Idebenone Treatment Mediates the Effect of Menadione Oxidative Stress Damage in Saccharomyces cerevisiae
Drug Metabolism Letters The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Oral GPIIb / IIIa Antagonists: What Went Wrong?
Current Pharmaceutical Design Preface
Current Molecular Medicine Structure-based Pharmacophore Clustering of Multi- Conformation Proteins: Application to Identify Novel and Diverse CypD Inhibitors
Current Proteomics Cerebrovascular Endothelin Receptor Upregulation in Cerebral Ischemia
Current Vascular Pharmacology Neurosteroids and Sporadic Alzheimers Disease
Current Alzheimer Research Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis
Current Vascular Pharmacology Edema, Inflammation and Fibrosis – Comparison Between Catecholamine- and Hypoxia-Induced Pulmonary Injuries
Vascular Disease Prevention (Discontinued) Thromboembolic Complications in Malignant Haematological Disorders
Current Vascular Pharmacology NADPH Oxidases and Inflammatory Bowel Disease
Current Medicinal Chemistry Cardiac Toxicity of Antineoplastic Anthracyclines
Current Medicinal Chemistry - Anti-Cancer Agents Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia
Current Drug Targets Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Current Pharmaceutical Design Therapeutic Effect of Ghrelin in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis
Current Pharmaceutical Design Ubiquitin and ubiquitin-like proteins in cardiac disease and protection
Current Drug Targets siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy The Role of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke: From Laboratory to Clinics
Current Vascular Pharmacology